Objective-Endothelial microparticles (EMP) are released from activated or apoptotic cells, but their effect on target cells and the exact way of incorporation are largely unknown. We sought to determine the uptake mechanism and the biological effect of EMP on endothelial and endothelial-regenerating cells. Methods and Results-EMP were generated from starved endothelial cells and isolated by ultracentrifugation. Caspase 3 activity assay and terminal deoxynucleotidyl transferase dUTP nick end labeling assay showed that EMP protect target endothelial cells against apoptosis in a dose-dependent manner. Proteomic analysis was performed to identify molecules contained in EMP, which might be involved in EMP uptake. Expression of annexin I in EMP was found and confirmed by Western blot, whereas the corresponding receptor phosphatidylserine receptor was present on endothelial target cells. Silencing either annexin I on EMP or phosphatidylserine receptor on target cells using small interfering RNA showed that the uptake of EMP by human coronary artery endothelial cells is annexin I/phosphatidylserine receptor dependent. Annexin I-downregulated EMP abrogated the EMPmediated protection against apoptosis of endothelial target cells. p38 activation was found to mediate camptothecin-induced apoptosis. Finally, human coronary artery endothelial cells pretreated with EMP inhibited camptothecin-induced p38 activation.
C oronary artery disease is the main cause of death in the industrialized world. The underlying disease, atherosclerosis, is initiated and propagated by a continuous damage of the vascular endothelium, leading to endothelial dysfunction. 1 The latter is not only a prerequisite of atherosclerosis but also largely influences the outcome of patients at cardiovascular risk or with coronary artery disease. 2 On the cellular level, endothelial dysfunction and subsequent plaque development are based on progressive endothelial cell (EC) apoptosis. In response to cell activation, dysfunction, injury, or apoptosis, cells shed small membrane vesicles, termed microparticles (MP). 3 Although MP can be found in the blood plasma of healthy individuals, dramatically increased numbers of circulating endothelial MP (EMP) have been reported in individuals with vascular diseases, including hypertension and atherosclerosis. 4, 5 However, MP are not merely inert debris that reflects cellular activation or injury. They have various physiological functions, including activation of inflammation and coagulation, and are important carriers of membrane components and bioactive molecules, playing essential roles in cell-cell crosstalk. MP have been involved in a series of gain-of-function phenomena by transferring transcription factors that induce expression of target genes, nucleic acids that are translated into biological active proteins, or mature proteins that promptly exert biological activities in recipient cells. [6] [7] [8] Although it has been shown that EMP may exert proinflammatory activities in professional phagocytic cells, cellular responses to MP in nonphagocytic cells include immunomodulation and anti-inflammatory responses. 9 The role and function of EMP on endothelial target cells and the mechanisms leading to the uptake of EMP in target cells are largely unknown. Here, we present evidence that EMP protect ECs against apoptosis and that incorporation of EMP by ECs is annexin-I/phosphatidylserine receptor (PSR) dependent.
Cell Culture and EMP Generation
Human coronary artery endothelial cells (HCAEC; PromoCell, Heidelberg, Germany) were cultured in EC growth media with endothelial growth media SupplementMix (Promocell) under standard cell culture conditions (37°C, 5% CO 2 ). Cells of passages 4 to 7 were used when 70% to 80% confluent. EMP were generated from HCAEC as previously described. 10 Briefly, confluent cells were starved by subjecting to media without growth media supplements for 24 hours to induce apoptosis of HCAEC. After starvation, the supernatant of apoptotic HCAEC was collected and centrifuged at 1500g for 15 minutes to remove cell debris. The supernatant was centrifuged (100 000g, 40 minutes) to pellet MP. The EMP obtained were washed in sterile PBS (pH 7.4) and then pelleted again at 100 000g. The pelleted EMP were resuspended in sterile PBS and used freshly. Using flow cytometry and TruCount tubes, EMP were analyzed, and the concentration was calculated by the following formula: (number of events for annexin V/number of events in TruCount bead region) × (number of TruCount beads per test/test volume; BD Biosciences, Franklin Lakes NJ). EMP were used at the concentration of 2000 AnnV + MP/μL for all experiments unless indicated otherwise.
Results

Characterization of EMP
EMP were generated from HCAEC in vitro as described. To further investigate the characteristics of MP isolated according to our protocol, flow cytometry analysis and electron microscope were used to evaluate size and cellular origin ( Figure 1 ). Most of the HCAEC-derived EMP had a size of 0.1 to 1 μm in diameter ( Figure 1A and 1D ), and the majority of EMP expressed phosphatidylserine (PS) and the EC marker CD31 ( Figure 1B and 1C ). Analysis of the size of isolated vesicles indicates that most of them comprise MP, which have a size from 0.1 to 1 μm. 3
EMP-Mediated Protection Against Apoptosis
Because EC apoptosis is one of the key elements in endothelial dysfunction and plaque progression, we first investigated how EMP, derived from apoptotic ECs, influence HCAEC undergoing apoptosis. Apoptosis of HCAEC pretreated with or without EMP was induced using camptothecin. Caspase 3 activity analysis revealed that camptothecin-induced apoptosis of HCAEC was significantly inhibited after pretreatment with 2000 EMP/μL (72.1±3.3 versus 100 ± 5.7; P<0.01, Figure 2A ). Treatment of HCAEC with different EMP concentrations revealed a dose-dependent beneficial effect of EMP on apoptosis in target cells (P<0.01 versus 400 EMP/μL; P<0.001 versus 200 EMP/μL and 20 EMP/μL; Figure 2A ). To confirm the antiapoptotic effects of EMP in HCAEC, additional terminal deoxynucleotidyl transferase dUTP nick end labeling experiments were performed ( Figure 2B ). Pretreatment with 2000 EMP/μL significantly reduced camptothecin-induced apoptosis in HCAEC (89.4 ± 4.3 versus 65.9 ± 8.6; P<0.001; Figure 2C ).
EMP Are Incorporated Into Target Cells
As EMP influence target cells in vitro, we next investigated whether EMP are incorporated by target cells. Therefore, HCAEC were incubated with calcein AM-labeled EMP, and incorporation of EMP was analyzed after different time points. Immunofluorescence staining revealed that EMP were clearly detectable in the EMP-treated cells and that EMP uptake in target HCAEC was time dependent (Figure 3 ). To confirm that EMP are incorporated into HCAEC, images were taken as Z-stacks, showing that EMP were internalized by HCAEC (Movie in the online-only Data supplement). Furthermore, uptake of EMP into early and late endothelial progenitor cells (EPC) was demonstrated by fluorescence microscopy ( Figure I in the online-only Data Supplement).
EMP Incorporation Is Annexin I/PSR Dependent
To find proteins expressed in EMP, which might be potentially involved in EMP incorporation into target cells, proteomic analysis was performed. Among abundantly expressed proteins present in EMP (n=2; Table) , annexin I in colocalization with PS on apoptotic cells has been shown to be involved in apoptotic cell recognition and engulfment by target cells through PSR. 11 Confirmatory Western blot analysis was carried out, demonstrating that annexin I is clearly expressed in EMP ( Figure 4A ). Additional Western blot analysis revealed that PSR is expressed on HCAEC, early outgrowth EPC, and late outgrowth EPC ( Figure 4B ). Expression of PSR on HCAEC was furthermore confirmed by immunofluorescence in resting condition and after camptothecin treatment. Staining without permeabilization revealed that PSR is clearly detectable in the plasma membrane ( Figure 4C ), whereas staining using permeabilization showed that PSR is colocalized in the plasma membrane and nuclei ( Figure  II in the online-only Data Supplement). Both annexin I and PSR are important molecules in the phagocytic uptake of apoptotic cell fragments. 11 To evaluate whether nonprofessional phagocytic cells (eg, ECs) use this pathway to incorporate MP, annexin I expression on EMP and PSR expression on target cells were downregulated using small interfering RNA. Interestingly, EMP uptake was significantly diminished in target HCAEC treated with annexin I-downregulated EMP (EMP small interfering RNA annexin I) compared with control EMP (P<0.01; n=3-5; Figure 4D ). Vice versa, inhibition of PSR expression in HCAEC by small interfering RNA significantly reduced EMP uptake by target cells (P<0.01; n=3-5; Figure 4E ). An efficient downregulation of annexin I in EMP generated from annexin I small interfering RNA-transfected cells was confirmed by Western blot ( Figure III in the online-only Data Supplement). An ELISA-based assay evaluating EMP uptake in a quantitative manner confirmed the observed results: the uptake of annexin I-downregulated EMP was significantly reduced compared with control (**P<0.01 versus HCAEC+EMP; n=5; Figure  4F ). In addition, downregulation of PSR in HCAEC significantly reduced EMP uptake (***P<0.001; n=5; Figure 4F ). The involvement of PSR in EMP uptake was further confirmed by using a specific antibody to block PSR ( Figure  IV These data support the concept that the annexin I/PSR pathway is essential for the uptake of EMP into HCAEC. , and late EPC) was demonstrated by Western blot. C, PSR expression (red) in HCAEC and camptothecin-treated HCAEC was analyzed using immunofluorescence in the absence of cell permeablization. Nuclei were stained with DAPI (blue). HCAEC stained with only secondary antibody were used as negative control. Magnification, ×200. D, Small interfering RNA (siRNA) experiments were performed to evaluate the role of annexin I in the uptake of EMP. HCAEC were transfected using annexin I siRNA or siRNA control followed by PKH staining (red). EMP were generated after starvation and coincubated with target HCAEC. After 3 washing steps, cells were stained for Hoechst (blue) and Flk-1 (green), and EMP uptake was determined by fluorescence microscopy. Annexin I downregulation in EMP resulted in a significantly reduced uptake of EMP in HCAEC (**P<0.01 vs EMP and siRNA control; n=3-5). Bar, 200 μm. E, Identical experiments were performed using siRNA directed against the PSR in HCAEC. Downregulation of PSR resulted in a strong abrogation of EMP uptake in HCAEC (**P<0.01 vs HCAEC and siRNA control; n=3-5). F, An ELISA-based assay evaluating EMP uptake in a quantitative manner confirmed the observed results. The ratio between PKH (EMP) and Hoechst (target cells) was used to quantify EMP uptake. Coincubation of HCAEC with annexin I-downregulated EMP significantly reduced the PKH/Hoechst ratio compared with coincubation with EMP (**P<0.01 vs HCAEC+EMP; n=5). Vice versa, downregulation of PSR in HCAEC reduced EMP uptake significantly (***P<0.001 vs HCAEC+EMP; n=5).
Inhibition of Annexin I/PSR-Mediated Uptake Abrogates MP-Mediated Inhibition of Apoptosis
To evaluate whether the disruption of the annexin I/PSR axis influences the effect of EMP on apoptosis, annexin I-downregulated EMP were generated. Annexin I-downregulated EMP abrogated the EMP-induced inhibition of apoptosis in endothelial and endothelial-regenerating cells: HCAEC, early EPC, and late EPC ( Figure 5 ; early EPC P<0.05, HCAEC P<0.05, late EPC P<0.01; n=4-6). These results further confirmed the importance of the annexin I/PSR-dependent pathway of EMP uptake by target cells.
Camptothecin Induced Apoptosis in HCAEC in a p38-Dependent Manner
To find a possible pathway how EMP inhibited camptothecininduced apoptosis in HCAEC, we first investigated the mechanism by which camptothecin induced apoptosis. Camptothecin has been shown to activate mitogen-activated protein kinases (MAPKs), which are involved in cell survival and apoptosis. 12, 13 Among those, p38 activation mediated camptothecin-induced apoptosis in human gastric cancer cell lines. 14 Therefore, we sought to determine whether p38 activation is involved in camptothecin-induced apoptosis in ECs. We performed Western blot analysis on p38 and its active form phospho-p38 at different time points after camptothecin stimulation, which showed that p38 was activated to phospho-p38 within 1 hour after camptothecin treatment ( Figure 6A ). To confirm the potential pathway of p38 activation in camptothecin-induced apoptosis, we used the highly specific p38 inhibitor SB-203580 for the following experiments. Interestingly, caspase 3 activity assay revealed that pretreatment with SB-203580 significantly reduced camptothecin-induced apoptosis in target HCAEC ( Figure 6B; n=6; P<0.01) . These data suggest that p38 is actively involved in camptothecin-induced apoptosis.
EMP Inhibited Camptothecin-Induced Activation of p38
As we found out that EMP inhibited camptothecin-induced apoptosis and p38 activation was involved in camptothecininduced apoptosis, we hypothesized that EMP might protect HCAEC by inhibiting p38 activity. To further clarify the underlying mechanism, HCAEC pretreated with EMP were stimulated with camptothecin. Subsequent Western blot analysis on p38 and phospho-p38 at different time points after camptothecin stimulation showed that camptothecin-induced activation of p38 was inhibited by EMP treatment ( Figure 6C ). Next, we sought to determine how EMP inhibit camptothecin-induced p38 activation. The major mechanism leading to inactivation of MAPKs is mediated by MAPK phosphatases (MKPs), which dephosphorylate and thereby inactivate the MAPKs. 15 Interestingly, MAPK phosphatase-1 (MKP-1), which plays an essential physiological role in the negative regulation of the MAPKs, has been shown to be strongly regulated by annexin I. 16 camptothecin treatment reduced MKP-1 expression in endothelial target cells. Interestingly, EMP pretreatment restored MKP-1 expression after 1 hour of camptothecin treatment ( Figure 6D ). These data suggest that annexin I-containing EMP reactivate MKP-1 after camptothecin treatment and thereby reduce p38 activation.
Discussion
In this study, we demonstrate that EMP uptake by target cells is annexin I/PSR dependent. Incorporation of EMP inhibits camptothecin-induced apoptosis in endothelial and endothelial-regenerating cells. Inhibition of p38 activity by annexin I-containing EMP is possibly involved in EMP-mediated protection against apoptosis.
What is the potential underlying biological concept of these observations? Recent evidences support the notion that EMP are increased in all conditions of systemic EC damage, including thrombotic thrombocytopenic purpura, lupus anticoagulant, and multiple sclerosis, as well as in cardiovascular disease. 4, 5, [18] [19] [20] [21] [22] [23] In patients with acute coronary syndromes, EMP are significantly increased compared with stable coronary artery disease. 24 It has been speculated that the apoptotic ECs need membrane blebbing and EMP formation to get rid of noxious agents. 25, 26 In this context, previous publications reported that EMP may induce thrombosis, inflammation, apoptosis, and endothelial dysfunction. These previous data have consolidated the impression that EMP are deleterious in vascular homeostasis. Interestingly, EMP have additional biological vector function, which may shed a different light on their role in pathologies. Uptake of MP by nonphagocytic cells has been associated with anti-inflammatory pathway activation. When looking at the endothelium, one can speculate that apoptosis of ECs with concomitant release of MP is an important feedback mechanism, protecting adjacent ECs against further cell damage. The observation that EMP uptake prevents apoptosis after a camptothecin challenge argues for this hypothesis. Interestingly, neutrophil-derived MP have been shown to contain functionally active annexin I that confers them anti-inflammatory properties that inhibit IL-1βinduced leukocyte trafficking. 27 A more recent study revealed that apoptotic bodies derived from apoptotic ECs can transfer microRNA 126 to target cells, inducing CXCL12-dependent vascular protection in vitro and in vivo, which brings new insights into the mechanism on how MP influence target cells. 28 At present, there are several other known mechanisms on how MP transfer biological information. Mack et al 29 EPC-derived MP activate an angiogenic program in ECs by a horizontal transfer of mRNA. 30 Taking data together, the biological effects of EMP in maintaining vascular homeostasis appear to be more complex than initially thought. Whereas several mechanisms concerning the transfer of biological information by MP are well established, the uptake mechanisms of MP into target cells are still not clear. We could demonstrate that the annexin I/PSR axis seems to be an important mechanism for the EMP uptake by target cells and influences functional effects of EMP. Interestingly, Henson et al 31 have identified PSR as a key element in the regulation of the inflammatory status of an organism. In concert with our data, a recent study revealed PSR expression on ECs and externalization after EC activation. 32 Interestingly, based on our findings, the presence of PSR is not restricted to ECs but is also found on endothelial-regenerating progenitor cells. The function of PSR is still a matter of debate. Whereas Li et al 33 demonstrated in an elegant way that PSR is required for apoptotic cell removal in vitro and in vivo, another group demonstrated normal engulfment of apoptotic cells in PSR −/− mice. 34 However, we demonstrate that EMP uptake into ECs is PSR dependent.
Annexin I is a highly abundant intracellular protein, which is one of the best-characterized molecules of a group of calcium-and phospholipid-binding proteins. Arur et al 11 documented that, during apoptosis, annexin I translocates from the cytosol to the PS-rich area at the outer leaflet of the plasma membrane. Subsequently, annexin I acts as a bridging molecule between PS highly expressed in apoptotic cells and PSR in target cells and mediates apoptotic cell recognition and engulfment. In our experiments, inhibition of annexin I in EMP or PSR in HCAEC decreased the uptake of EMP by HCAEC, suggesting an involvement of the annexin I/PSR axis in EMP engulfment by nonprofessional phagocytes.
We demonstrated that camptothecin induced HCAEC apoptosis in a p38-dependent manner. Furthermore, EMP inhibited camptothecin-induced p38 activation and restored MKP-1 activation after camptothecin treatment. These findings, in accordance with other data, 16 suggest that annexin I-containing EMP regulate MKP-1 activity and thereby mediate antiapoptotic effects. However, whether it is annexin I in EMP that activates MKP-1 in target cells needs to be further investigated.
In conclusion, our findings may represent a novel feedback mechanism by which apoptotic ECs protect their neighboring cells from further cell damage in an EMP-mediated way. However, one limitation of the study is that, although characterization of size and surface markers suggests that most of the isolated vesicles comprise MP, theoretically we cannot completely rule out exosome contamination using a 100 000g centrifugation. Because microvesicle isolation protocols differ internationally between laboratories, standardized protocols for isolation of exosomes, MP, and apoptotic bodies by an international consensus are needed to clarify this point.
The concept of annexin I/PSR-mediated uptake of EMP into endothelial and endothelial-regenerating target cells is novel and, therefore, implies unresolved questions: (1) It is conceivable that activation of the PSR after MP-cell contact leads to the engulfment and internalization of MP (for review see Lauber et al), 35 but the exact way of postprocessing of EMP after activation of the PSR is currently unknown. (2) In future studies, it needs to be verified whether the protective effect of EMP is mediated through activation of PSR in target cells or the transfer of antiapoptotic molecules via MP.
